Evaluation of Clinical Pharmacists' Interventions in the Czech Republic

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064211%3A_____%2F16%3AN0000018" target="_blank" >RIV/00064211:_____/16:N0000018 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/62157124:16370/16:43874455

Výsledek na webu

<a href="https://www.ncbi.nlm.nih.gov/pubmed/27270831" target="_blank" >https://www.ncbi.nlm.nih.gov/pubmed/27270831</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1002/phar.1777" target="_blank" >10.1002/phar.1777</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Evaluation of Clinical Pharmacists' Interventions in the Czech Republic

Popis výsledku v původním jazyce

STUDY OBJECTIVES To determine the frequency of interventions, categorized by type of intervention and therapeutic class, made by a team of four clinical pharmacists over a 1-year period, and to assess the potential economic impact of these interventions. MEASUREMENTS AND MAIN RESULTS Clinical pharmacists' interventions were categorized by therapeutic class and divided into eight types: introduction of a drug, discontinuation of a drug, dosage change, route of administration change, recommendation to continue therapy, recommendation to perform further evaluation (e. g., laboratory assessment), reintroduction of a missing medication, and therapeutic drug monitoring (request to measure a drug concentration and provide its interpretation). All interventions accepted by the attending physicians were recorded by using a software application. For the evaluation of the economic impact of the interventions, published statistical data were used from the Institute of Health Information and Statistics of the Czech Republic. During the 1year period, the clinical pharmacists performed 1916 interventions. The most frequent intervention was drug discontinuation (27.9% of all interventions), and the drug category with the highest frequency of interventions was central nervous system drugs (25.1%). All interventions were accepted by the physicians. For the evaluation of potential economic impact, a select group of drugs was used, representing 14.4% of the interventions. The benefit: cost ratio was 3: 1.

Název v anglickém jazyce

Evaluation of Clinical Pharmacists' Interventions in the Czech Republic

Popis výsledku anglicky

STUDY OBJECTIVES To determine the frequency of interventions, categorized by type of intervention and therapeutic class, made by a team of four clinical pharmacists over a 1-year period, and to assess the potential economic impact of these interventions. MEASUREMENTS AND MAIN RESULTS Clinical pharmacists' interventions were categorized by therapeutic class and divided into eight types: introduction of a drug, discontinuation of a drug, dosage change, route of administration change, recommendation to continue therapy, recommendation to perform further evaluation (e. g., laboratory assessment), reintroduction of a missing medication, and therapeutic drug monitoring (request to measure a drug concentration and provide its interpretation). All interventions accepted by the attending physicians were recorded by using a software application. For the evaluation of the economic impact of the interventions, published statistical data were used from the Institute of Health Information and Statistics of the Czech Republic. During the 1year period, the clinical pharmacists performed 1916 interventions. The most frequent intervention was drug discontinuation (27.9% of all interventions), and the drug category with the highest frequency of interventions was central nervous system drugs (25.1%). All interventions were accepted by the physicians. For the evaluation of potential economic impact, a select group of drugs was used, representing 14.4% of the interventions. The benefit: cost ratio was 3: 1.

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FR - Farmakologie a lékárnická chemie

OECD FORD obor

—

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2016

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

PHARMACOTHERAPY

ISSN

0277-0008

e-ISSN

—

Svazek periodika

36

Číslo periodika v rámci svazku

7

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

8

Strana od-do

766-773

Kód UT WoS článku

000383595600154

EID výsledku v databázi Scopus

—